Colchicine in Acute Myocardial Infarction - New England Journal …
Nov 17, 2024 · A total of 7062 patients at 104 centers in 14 countries underwent randomization; at the time of analysis, the vital status was unknown for 45 patients (0.6%), and this information was most likely ...
Beta-Blockers after Myocardial Infarction and Preserved Ejection ...
Apr 7, 2024 · From September 2017 through May 2023, a total of 5020 patients were enrolled (95.4% of whom were from Sweden). The median follow-up was 3.5 years (interquartile range, 2.2 to 4.7).
The New England Journal of Medicine | Research & Review Articles …
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...
New England Journal of Medicine
The New England Journal of Medicine publishes new medical research, review articles, and editorial opinion on a wide variety of topics.
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe …
Oct 28, 2024 · A total of 901 patients underwent randomization; 455 patients were assigned to TAVR and 446 to clinical surveillance. The mean age of the patients was 75.8 years, the mean Society of Thoracic ...
Routine Spironolactone in Acute Myocardial Infarction
Nov 17, 2024 · We enrolled 7062 patients at 104 centers in 14 countries; 3537 patients were assigned to receive spironolactone and 3525 to receive placebo. At the time of our analyses, the vital status was ...
Continuing Medical Education - The New England Journal of …
Among patients with transthyretin amyloidosis with cardiomyopathy, the risk of death from any cause and recurrent cardiovascular events was lower with vutrisiran treatment than with placebo.
Article Types | NEJM Author Center
Original Article. Reports scientific results of original clinical research. See Example. Maximum words: 2,700 Elements: Abstract; Maximum of 5 tables and figures
Middle Meningeal Artery Embolization and Nonacute Subdural …
Nov 20, 2024 · Nonacute subdural hematoma is common among older persons. With an aging population and increasing use of antiplatelet and anticoagulant agents, subdural hematoma is projected to become the most ...
Durvalumab in Small-Cell Lung Cancer | NEJM
Dec 18, 2024 · To the Editor: Results of the phase 3 ADRIATIC trial (Oct. 10 issue)1 marked a breakthrough in the treatment of limited-stage small-cell lung cancer, but some questions remain unanswered.